India’s pharma exports crossed $ 30 billion in FY 2025, with the US to have a major market to have more than one third of the country’s pharma exports. This is a major achievement for the country. According to official trade data, pharma exports reached $ 30,467.32 million in FY 2025, which is 9 percent more than $ 27,851.70 million in FY 2024.
According to the data, in the month of March, pharma exports registered an increase of more than 30 percent on an annual basis, which increased from $ 2,805.71 million to $ 3,681.51 million in the same month of the last financial year. In the financial year 2025, exports to the US increased by 14.29 percent to $ 8,953.37 million. In the last financial year, India’s other countries living in pharma exports were UK, Brazil, France and South Africa.
Meanwhile, a report last month said that the domestic pharmaceuticals market is expected to increase by 8-9 percent on an annual basis in FY 2026. India Ratings and Research (Ind-Ra) report said that the growth in the sector for FY 2025 will be 7.5-8.0 percent on an annual basis for FY 2025. Krishnanath Munde, Associate Director of India Ratings and Research, said that the region recorded an increase of 6.5 percent annually in FY 2024 and 9.9 percent in FY 2023. “In February, Pharma Bazaar gave a revenue of 7.5 percent on an annual basis.
The report said that this increase has been recorded due to price and increase in new launch. The price was recorded at 5.2 percent on an annual basis and a 2.4 percent increase was recorded on an annual basis for the new launch, while the volume growth remained negative 0.2 percent on an annual basis. In FY 2025, the region registered an annual growth of 7.3 percent on an average. This includes price increase (5.5 percent), new launch increase (2.7 percent) and volume growth. There is a boom in production in the pharma region in the country. According to a report by McKinse & Co., the Indian Pharma sector has increased from 8 percent CAGR and 2024 has also seen an increase of 9 percent in export rates. The report said that the country has also become the world’s largest supplier of generic medicines, whose pharma export growth is 9 percent, which is almost double the global average.
(This news has not been edited by the NewsDeskReport team. It has been published directly from the syndicate feed.)